(Q44629561)

4 December 2017

title

A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation (English)

1 reference

hypertrophic cardiomyopathy

4 December 2017

main subject

1 reference

familial hypertrophic cardiomyopathy

inferred from title

1 reference

Jeffery D Molkentin

6

0 references

Bruce J Aronow

4

object named as

Bruce Aronow

1 reference

4 December 2017

author name string

Rethinasamy Prabhakar

1

1 reference

4 December 2017

Natalia Petrashevskaya

2

1 reference

4 December 2017

Arnold Schwartz

3

1 reference

4 December 2017

Greg P Boivin

5

1 reference

4 December 2017

David F Wieczorek

7

1 reference

4 December 2017

publication date

1 September 2003

1 reference

Molecular and Cellular Biochemistry

4 December 2017

published in

1 reference

4 December 2017

volume

251

1 reference

4 December 2017

issue

1-2

1 reference

4 December 2017

page(s)

33-42

1 reference

Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy

4 December 2017

cites work

1 reference

12 December 2020

Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice

1 reference

12 December 2020

Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis

1 reference

12 December 2020

A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice

1 reference

12 December 2020

Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function.

1 reference

12 December 2020

Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy

1 reference

12 December 2020

Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies

1 reference

12 December 2020

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

12 December 2020

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

1 reference

12 December 2020

Transgenic Galphaq overexpression induces cardiac contractile failure in mice

1 reference

12 December 2020

Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction

1 reference

12 December 2020

Effect of Hypertrophic Cardiomyopathy Mutations in Human Cardiac Muscle α -tropomyosin (Asp175Asn and Glu180Gly) on the Regulatory Properties of Human Cardiac Troponin Determined by in vitro Motility Assay

1 reference

12 December 2020

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

12 December 2020

Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition

1 reference

12 December 2020

Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart

1 reference

12 December 2020

Animal models of hypertrophic cardiomyopathy

1 reference

12 December 2020

Animal models of familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1025409227350

1 reference

Dimensions Publication ID

4 December 2017

1029493969

0 references

1 reference